AirStrip's president, Dr. Matt Patterson, demonstrates the company's mobile applications that are used ...
By Peggy O'Hare, San Antonio Express-News Children's Hospital of San Antonio opened a new clinical research ...
Admittance Technologies is committed to improving the quality of life of patients with heart disease through innovative electrical engineering solutions.
San Antonio’s innovative nanotherapy company working to improve the safety and efficacy of chemotherapy drugs.
BD, a leading global medical technology company that manufactures and sells medical devices, instrument systems and reagents, is dedicated to improving people’s health throughout the world. BD is focused on improving drug therapy, enhancing the quality and speed of diagnosing infectious diseases, and advancing research and discovery of new drugs and vaccines. Founded in 1897, BD employs over 27,000 people worldwide and serves healthcare institutions, life science researchers, clinical laboratories, industry and the general public.
Biomedical Development Corporation is commercializing a portfolio of pharmaceuticals that decrease bacterial bioburden in the mouth, reduce chronic inflammation, and subsequently improve systemic health. Biomedical Development Corporation has two drugs in Phase 2 clinical trials.
BME’s business initiatives as a medical device manufacturer and research service provider have allowed it to increase the medical community’s knowledge in osteoporosis, bone healing, and bone replacement materials. BME's strategy is focused on minimally invasive orthopaedic instrumentation and implants that elicit a biologic response.
Cancer Insight is a clinical research organization in the area of cancer immunotherapy. Through its subsidiary, CI is also discovering and developing innovative cancer immunotherapies.
CellRight Technologies LLC is a biotech company that specializes in regenerative medicine and is dedicated to the development of innovative osteobiologic and wound care scaffolds that enhance healing opportunities of defects created by trauma and disease.
CMI, a woman-owned, small disadvantaged business, is a biotechnology and software engineering company with core competencies in biological research, bioinformatics, modeling, and simulation. CMI's commercial product is an Electronic Health Record called SevocityTM.
Cruz Medical Enterprises, LLC (CME) is a unique sales and marketing distribution partner for next-generation medical devices, biologics, and would care products.
As we earlier did with the Heart Sherpa™ it is our intention to only take on those challenges that can demonstrate the potential - and the likelihood - to fundamentally change patient care experiences and outcomes. In order to cost-effectively and timely be able to address unmet societal healthcare needs, Disruptive Technologies intends to identify and collaborate with professionals and research institutions across the Country and across the World.
A contract development and manufacturing organization (CDMO) offering full service sourcing solutions for the world’s leading pharmaceutical, biotechnology and healthcare companies.
Electrochemical Oxygen Concepts, Inc. (EO2 Concepts™) is an innovative wound care company based in San Antonio, TX. Its first product, the TransCu O2™ device, is a unique, non-invasive, electrochemical tissue oxygenation system intended for use with lower-cost moist wound dressings for the treatment of diabetic foot ulcers, venous leg ulcers, pressure ulcers and other skin wounds through the continuous diffusion of oxygen.
Evestra seeks to improve the health and wellness of women around the world through innovative technologies and commercially viable products focused primarily on fertility control, gynecological disorders and oncology.
A development stage oncology company focused on therapeutics which deliver a potent, unique and patented drug directly to tumors.
INCELL is a recognized human stem cell therapy company, and FDA-registered manufacturer and biobank cryostorage facility. INCELL manufactures products for itself and its clients, and provides contract services in product development, pre-clinical testing, personalized medicine and clinical trials in the areas of regenerative medicine, cancer, vaccines and infectious diseases.
iTraumaCare™ is addressing unmet needs in the field of emergency medicine by developing, manufacturing, and commercializing point of injury solutions to treat common causes of preventable death in traumatic injury scenarios.
Medical Care Innovations is the parent company of EndoMune Advanced Probiotic, the only GI-developed probiotic on the market for adult and children.
At Medtronic, Innovating for life means we’re committed to finding more ways to help more people around the world. Constantly pushing the limits of medical technology. Driven by our deep understanding of the human body and our collaboration with physicians, we're transforming technology to treat patients across the entire care continuum. Our innovations help physicians diagnose diseases earlier, treat patients with the least amount of disruption possible, and help alleviate symptoms throughout the patient's life.
Metric Medical Devices is focused on developing internal bone fixation implants for the hand, wrist, foot & ankle that speed healing and minimize non-healing by pulling together and compressing bone.
For more than sixty years, privately held Mission Pharmacal has been dedicated to identifying unmet health needs and developing innovative products to meet them.
NuPak provides a broad array of development, prototypes, testing, injection molding and packaging services for the entrepreneur, inventor, and large medical corporations. We specialize in contract medical manufacturing.
A strategic consulting firm for medical device companies and biotechnology.
QualTex Laboratories performs testing services for clients that collect, prepare, and distribute FDA regulated blood components/biological products for human therapies. Tests performed are used to qualify blood/plasma donors and support global public safety.
Rochal Industries is a privately owned bioscience company focusing on the development of new polymeric materials for wound and burn care treatment. Rochal licenses its intellectual property to companies capable of commercializing the resulting products.
Seno Medical Instruments Inc. is focused on the early detection of cancer through the use of its patented opto-acoustic imaging technology.
StemBioSys manufactures and develops novel, proprietary stem cell technologies to meet the promise of regenerative medicine in a surging global market. Housed in San Antonio, StemBioSys is led by an experienced management and scientific team.
Teleflex Vidacare Business Unit is the developer of a broad technology platform that is defining the field of intraosseous (inside the bone) medicine. Current applications include vascular access, emergency and disaster medicine, oncology and spinal surgery. The EZ-IO® Intraosseous Vascular Access System provides immediate vascular access for the delivery of essential medications and fluids, while complementing the current ARROW® CVC and PICC portfolio. Teleflex now provides a complete product offering across the continuum of care for vascular access. The Vidacare® OnControl® Bone Marrow System provides the first significant advance in bone marrow procedures in decades. The OnControl® Bone Access System provides rapid and safe access to vertebrae during vertebroplasty.
ViroXis is a biopharmaceutical company focused on developing and commercializing innovative, proprietary, botanical pharmaceuticals derived from Sandalwood oil.
Vivo Biosciences Inc. provides ‘all-human’ 3-D bioassays with HuBiogel™ emulating the biology of normal and disease tissues for drug efficacy, toxicity and therapy prediction.
Xenex was founded to significantly reduce the number of healthcare associated infections that destroy the lives of millions of patients and their families by perfecting and monitoring the use of pulsed xenon UV (PX-UV) disinfection to decontaminate patient care environments.
Shepherd Kaplan LLC is an independent Investment Advisory firm providing consulting, educational and investment management services to institutional and private investors, with a focus on transparency as the key to successfully empowering our clients to achieve their financial objectives.
The Targeted Technology Funds are focused on early stage investments in companies that we believe can advance ground breaking or disruptive technologies to significantly improve the practice of medicine and patient outcomes. We also favor technologies that can positively improve the efficiency, cost, or functionality of the development and manufacture of life science products.
The Texas Technology Development Center (T3DC) is a not for profit economic development subsidiary of the Texas Research and Technology Foundation. T3DC manages a seed investment fund and a business accelerator.